From the Research
Thalidomide Therapy Duration
The duration of thalidomide therapy for tuberculous optochiasmatic arachnoiditis is not explicitly stated in the provided studies. However, the following information can be gathered:
- Thalidomide should be considered in children compromised by tuberculosis abscesses and tuberculous-related optochiasmic arachnoiditis 1, 2.
- The studies do not provide specific information on the duration of thalidomide therapy for this condition.
- In a different context, thalidomide was given to children with transfusion-dependent thalassemia for a duration of 6 months 3.
Key Points
- Thalidomide is considered for children with tuberculous optochiasmatic arachnoiditis.
- The duration of thalidomide therapy for this condition is not specified in the provided studies.
- Thalidomide has been used for 6 months in children with transfusion-dependent thalassemia, but this may not be directly applicable to tuberculous optochiasmatic arachnoiditis.